ArticleBlood advances2025

YX0798 is a highly potent, selective, and orally effective CDK9 inhibitor for treating aggressive lymphoma.

Vivian Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.